Back to GetFilings.com



Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 


 

 

FORM 10-Q

 

 

(Mark One)

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the Quarterly Period ended June 30, 2003

 

 

OR

 

 

¨ TRANSITIONAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from              to             

 

 

Commission file number 001-31513

 

 


 

 

WELLCHOICE, INC.

(Exact name of registrant as specified in its charter)

 

 

DELAWARE   71-0901607
(State or other jurisdiction of Incorporation or organization)   (I.R.S. Employer Identification Number)
11 WEST 42ND STREET NEW YORK, NEW YORK   10036
(Address of principal executive offices)   (Zip Code)

 

 

Registrant’s telephone number, including area code: (212) 476-7800

 

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x     No ¨

 

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨    No x

 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. 83,490,477 shares of common stock, $0.01 par value, and one share of Class B common stock, $0.01 par value per share, as of July 23, 2003.

 

 



Table of Contents

WellChoice, Inc and Subsidiaries

 

INDEX TO FORM 10-Q

 

          Page

PART I FINANCIAL INFORMATION

   3

Item 1.

   Financial Statements    3
     Consolidated Balance Sheets at June 30, 2003 (Unaudited) and December 31, 2002    3
     Consolidated Statements of Income for the Three Months Ended June 30, 2003 and 2002 (Unaudited) and Six Months Ended June 30, 2003 (Unaudited) and 2002    5
     Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2003 and 2002 (Unaudited)    6
     Notes to Consolidated Financial Statements (Unaudited)    7
     Report of Independent Accountants    15

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    16

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    32

Item 4.

   Controls and Procedures    33

PART II OTHER INFORMATION

   34

Item 1.

   Legal Proceedings    34

Item 4.

   Submission of Matters to a Vote of Security Holders    35

Item 5.

   Other Information    36

Item 6.

   Exhibits and Reports on Form 8-K    36

SIGNATURES

   38

INDEX TO EXHIBITS

   39

 

2


Table of Contents

PART I

FINANCIAL INFORMATION

 

Item 1.   Financial Statements

 

WellChoice, Inc. and Subsidiaries

 

Consolidated Balance Sheets

 

     June 30,
2003


   December 31,
2002


     (Unaudited)     
     (In thousands)

Assets

             

Investments:

             

Fixed maturities, at fair value (amortized cost: $930,772 and $846,617)

   $ 952,325    $ 863,290

Marketable equity securities, at fair value (cost: $60,764 and $47,022)

     63,339      44,548

Short-term investments

     33,042      359,490

Other long-term equity investments

     30,349      28,220
    

  

Total investments

     1,079,055      1,295,548

Cash and cash equivalents

     832,618      487,431
    

  

Total investments and cash and cash equivalents

     1,911,673      1,782,979

Receivables:

             

Billed premiums, net

     131,924      111,082

Accrued premiums

     268,317      247,729

Other amounts due from customers, net

     87,798      94,475

Notes receivable, net

     12,163      12,059

Advances to hospitals, net

     7,330      124

Accrued investment income

     7,701      9,829

Miscellaneous, net

     103,910      70,644
    

  

Total receivables

     619,143      545,942

Property, equipment and information systems, net of accumulated depreciation

     92,447      100,790

Prepaid pension expense

     48,360      45,209

Deferred taxes, net

     235,483      268,948

Other

     38,971      33,587
    

  

Total assets

   $ 2,946,077    $ 2,777,455
    

  

 

See notes to consolidated financial statements.

 

3


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Consolidated Balance Sheets

 

     June 30,
2003


   December 31,
2002


 
     (Unaudited)       
     (In thousands, except share
and per share data)
 

Liabilities and stockholders’ equity

               

Liabilities:

               

Unpaid claims and claims adjustment expense

   $ 598,348    $ 559,924  

Unearned premium income

     92,006      127,503  

Managed cash overdrafts

     170,843      170,270  

Accounts payable and accrued expenses

     103,049      111,842  

Advance deposits

     110,520      137,762  

Group and other contract liabilities

     157,929      112,870  

Postretirement benefits other than pensions

     144,500      143,736  

Obligations under capital lease

     46,152      47,700  

Other

     183,519      129,586  
    

  


Total liabilities

     1,606,866      1,541,193  

Stockholders’ equity:

               

Class A common stock, $0.01 par value, 225,000,000 shares authorized; 83,490,477 shares issued and outstanding

     835      835  

Class B common stock, $0.01 per share value, one share authorized; one share issued and outstanding

     —        —    

Preferred stock, $0.01 per share value, 25,000,000 shares authorized; none issued and outstanding

     —        —    

Additional paid-in capital

     1,255,566      1,255,566  

Retained earnings (deficit)

     57,974      (38,542 )

Accumulated other comprehensive income

     24,836      18,403  
    

  


Total stockholders’ equity

     1,339,211      1,236,262  
    

  


Total liabilities and stockholders’ equity

   $ 2,946,077    $ 2,777,455  
    

  


 

See notes to consolidated financial statements.

 

4


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Consolidated Statements of Income

 

     Three months ended
June 30


    Six months ended
June 30


 
     2003

    2002

    2003

    2002

 
     (Unaudited)     (Unaudited)        
     (In thousands, except share and per share date)  

Revenue:

                                

Premiums earned

   $ 1,247,047     $ 1,203,910     $ 2,413,588     $ 2,359,817  

Administrative service fees

     113,563       99,650       222,487       194,298  

Investment income, net

     11,561       17,833       24,917       34,409  

Net realized investment gains (losses)

     1,193       (348 )     4,306       (406 )

Other income, net

     1,147       597       1,291       13,624  
    


 


 


 


Total revenue

     1,374,511       1,321,642       2,666,589       2,601,742  

Expenses:

                                

Cost of benefits provided

     1,069,772       1,048,607       2,069,025       2,057,006  

Administrative expenses

     219,303       209,628       429,145       401,312  

Conversion and IPO expenses

     —         3,315       —         3,628  
    


 


 


 


Total expenses

     1,289,075       1,261,550       2,498,170       2,461,946  
    


 


 


 


Income from continuing operations before income taxes

     85,436       60,092       168,419       139,796  

Income tax (expense) benefit

     (36,661 )     2       (71,903 )     (20 )
    


 


 


 


Income from continuing operations

     48,775       60,094       96,516       139,776  

Loss from discontinued operations, net of taxes of $0

     —         (6 )     —         (1,056 )
    


 


 


 


Net income

   $ 48,775     $ 60,088     $ 96,516     $ 138,720  
    


 


 


 


Basic and diluted net income per common share:

   $ 0.59             $ 1.16          

Shares used to compute net income per common share, based on weighted average shares outstanding January 1, 2003 to June 30, 2003

     83,490,478               83,490,478          

 

See notes to consolidated financial statements.

 

5


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Consolidated Statements of Cash Flows

 

     Six months ended June 30

 
     2003

    2002

 
     (Unaudited)        
     (In thousands)  

Cash flows from operating activities

                

Net income

   $ 96,516     $ 138,720  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     18,385       16,084  

Net realized (gain) loss on sales of investments

     (4,307 )     406  

(Credit) provision for doubtful accounts

     (67 )     2,245  

Accretion of discount, net

     1,459       (2,114 )

Equity in earnings of other long-term equity investments

     (1,348 )     (1,189 )

Deferred income tax expense (benefit)

     30,001       (29,380 )

Other

     (3,151 )     (2,943 )

Changes in assets and liabilities:

                

Billed and accrued premiums receivables

     (40,262 )     (1,830 )

Other customer receivable

     6,335       1,486  

Long-term notes receivable

     (105 )     (1,594 )

Advances to hospitals

     (7,394 )     (3,526 )

Accrued investment income

     2,149       (2,883 )

Insurance proceeds receivable

           10,521  

Miscellaneous receivables

     (49,125 )     (893 )

Other assets

     (5,384 )     (15,066 )

Unpaid claims and claims adjustment expenses

     38,424       (6,015 )

Unearned premium income

     (35,497 )     (33,749 )

Managed cash overdrafts

     573       2,893  

Accounts payable and accrued expenses

     (442 )     (39,098 )

Advance deposits

     (27,242 )     (57,099 )

Group and other contract liabilities

     45,059       20,844  

Postretirement benefits other than pensions

     764       6,145  

Other liabilities

     38,817       1,478  
    


 


Net cash provided by operating activities

     104,158       3,443  
    


 


Cash flows from investment activities

                

Purchases of property, equipment and information systems

     (10,467 )     (15,536 )

Proceeds from sale of property, equity and information systems

     426       1,736  

Purchases of available for sale investments

     (704,534 )     (712,366 )

Proceeds from sales and maturities of available for sale investments

     957,152       689,259  
    


 


Net cash provided by (used) in investing activities

     242,577       (36,907 )
    


 


Cash flows from financing activities

                

Decrease in capital lease obligations

     (1,548 )     (1,179 )
    


 


Net cash used in financing activities

     (1,548 )     (1,179 )
    


 


Net change in cash and cash equivalents

     345,187       (34,643 )

Cash and cash equivalents at beginning of period

     487,431       408,588  
    


 


Cash and cash equivalents at end of period

   $ 832,618     $ 373,945  
    


 


Supplemental disclosure:

                

Income taxes paid

   $ 27,801     $ 47,293  
    


 


 

See notes to consolidated financial statements.

 

6


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

 

June 30, 2003

(Dollars in Thousands)

 

1. For-Profit Conversion and Initial Public Offering

 

On November 7, 2002, Empire HealthChoice, Inc. (“HealthChoice”) converted from a not-for-profit health service corporation to a for-profit accident and health insurer under the New York insurance laws and the converted HealthChoice issued all of its authorized capital stock to the New York Public Asset Fund (the “Fund”) and The New York Charitable Asset Foundation (the “Foundation”). The Fund and the Foundation then received their respective shares of WellChoice, Inc. (“WellChoice”) common stock in exchange for the transfer of all the outstanding shares of HealthChoice to a wholly-owned subsidiary of WellChoice. WellChoice was formed in August 2002 as a Delaware corporation to be the for-profit parent holding company for HealthChoice and subsidiaries (collectively, the “Company”) after the conversion. Pursuant to the plan of conversion, WellChoice issued 82,300,000 shares to the Fund and the Foundation and completed an initial public offering of 19,199,000 shares of common stock, consisting of 18,008,523 shares that were sold by the Fund and Foundation and 1,190,477 newly issued shares of common stock sold by WellChoice. After deducting the underwriting discount, net proceeds to WellChoice were approximately $27,990.

 

The conversion was accounted for as a reorganization using the historical carrying values of the HealthChoice’s assets and liabilities. Immediately following the conversion, HealthChoice’s unassigned reserves were reclassified to par value of common stock and additional paid-capital. Concurrently, HealthChoice became a wholly-owned subsidiary of WellChoice. The costs of the conversion were recognized as an expense.

 

2. Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. Operating results for the three month and six months period ended June 30, 2003 are not necessarily indicative of results that may be expected for the year ending December 31, 2003.

 

For further information, refer to the consolidated financial statements and footnotes thereto included in the WellChoice’s Annual Report on Form 10-K (File No. 001-31513), filed with the SEC for the fiscal year ended December 31, 2002.

 

7


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

2. Basis of Presentation (continued)

 

The following table represents total other comprehensive income for the six months ended June 30, 2003 and 2002:

 

     Six months ended
June 30,


 
     2003

   2002

 

Net income

   $ 96,516    $ 138,720  

Other comprehensive income, net of tax:

               

Unrealized gain (loss) on securities available-for-sale during the six months ended June 30, net of tax of $4,721 and $(1,792), respectively

     8,768      (3,328 )

Less: reclassification adjustment for gains (losses) for the six months ended June 30, included in net income, net of tax of $1,257 and $(142), respectively

     2,335      (264 )
    

  


Total comprehensive income

     6,433      (3,064 )
    

  


Comprehensive income

   $ 102,949    $ 135,656  
    

  


 

3. Market Stabilization Pools

 

The Company is required to participate in Market Stabilization and Stop Loss Pools (“Pools”) as established by the State of New York. Contributions and recoveries under the Pools are estimated based upon information received by the administrator of the Pools and are adjusted as new information becomes known. In June 2003, the Company received the data necessary to record a receivable in the amount of $44,000 related to Pool years 2000 through 2002, and the six months ended June 30, 2003. The Company believes the State of New York will place restrictions on the recoverable related to Pool years 2000 through 2002, and will require the Company to use the funds to ameliorate future Medicare Supplemental rate increases. Accordingly, we have established a premium stabilization reserve in the amount $39,200.

 

8


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

4. Income Taxes

 

WellChoice and its subsidiaries file a consolidated federal income tax return. WellChoice currently has a tax sharing agreement in place with all of its subsidiaries. In accordance with the Company’s tax sharing agreement, the Company’s subsidiaries pay federal income taxes to WellChoice based on a separate company calculation.

 

The significant components of the provision for income tax expense (benefit) are as follows:

 

     Three months ended
June 30


    Six months ended
June 30


 
     2003

   2002

    2003

   2002

 

Current tax expense

   $ 21,286    $ 13,172     $ 40,884    $ 29,399  

Deferred tax expense (benefit)

     15,375      (13,174 )     31,019      (29,379 )
    

  


 

  


Income tax expense (benefit)

   $ 36,661    $ (2 )   $ 71,903    $ 20  
    

  


 

  


 

A reconciliation of income tax computed at the federal statutory tax rate of 35% to total income tax is as follows:

 

     Three months ended
June 30


    Six months ended
June 30


 
     2003

   2002

    2003

    2002

 

Income tax at prevailing corporate tax rate applied to pre-tax income

   $ 29,902    $ 21,030     $ 58,946     $ 48,559  

(Increase) decrease:

                               

IRC Sec. 833(b) special deduction

     —        (28,584 )     —         (54,267 )

Change in valuation reserve

     —        8,632       —         6,406  

State and local taxes, net of federal income tax benefit

     1,209      382       8,057       785  

Additional tax expense due to New

                               

York State tax legislation

     5,374      —         5,374       —    

Other

     176      (1,462 )     (474 )     (1,463 )
    

  


 


 


Income tax expense (benefit)

   $ 36,661    $ (2 )   $ 71,903     $ 20  
    

  


 


 


 

9


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

4. Income Taxes (continued)

 

At June 30, 2002 HealthChoice maintained a valuation allowance on its regular tax net operating loss carryforwards and certain other temporary differences due to uncertainty in its ability to utilize these assets within an appropriate period. The use of these assets was largely dependent on the conversion and future positive taxable income. Because the approval of HealthChoice’s plan of conversion by the New York State Insurance Department removed the uncertainty of the conversion, the Company concluded in the third quarter of 2002 that the valuation allowance related to these assets was no longer necessary.

 

Prior to January 1, 1987, HealthChoice was exempt from federal income taxes. With the enactment of the Tax Reform Act of 1986, HealthChoice, and all other Blue Cross and Blue Shield plans, became subject to federal income tax. Among other provisions of the Internal Revenue Code, these plans were granted a special deduction (the “833(b) deduction”) for regular tax calculation purposes.

 

The 833(b) deduction is calculated as the excess of 25% of the incurred claim and claim adjustment expenses for the tax year over adjusted surplus, as defined, limited to taxable income. The amount of 833(b) deductions utilized in each tax year is accumulated in an adjusted surplus balance. Once the cumulative adjusted surplus balance exceeds the 833(b) deduction for the current taxable year, the deduction is eliminated. As a result of the 833(b) deduction, HealthChoice has incurred no regular tax liability, but in profitable years, has paid taxes at the alternative minimum tax rate of 20%.

 

During the fourth quarter of 2002, the Company reevaluated its tax position for financial statement purposes related to HealthChoice’s ability to utilize the Section 833(b) deduction and determined that when HealthChoice converted to a for-profit entity, its ability to utilize the Section 833(b) deduction was uncertain. No authority directly addresses whether a conversion transaction will render the 833(b) deduction unavailable. The Company is aware, however, that the IRS has taken the position related to other Blue Cross Blue Shield plans that a conversion could result in the inability of a Blue Cross Blue Shield plan to utilize the 833(b) deduction. In light of the absence of governing authority, while the Company continues to take the deduction on its tax returns after the conversion, the Company has assumed, for financial statement reporting purposes, that the deduction will be disallowed. Accordingly, the Company’s income tax provision for the quarter ended June 30, 2003 assumes the utilization of approximately $19,000 regular operating loss carryforwards for financial reporting purposes in excess of those utilized for tax purposes.

 

10


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

4. Income Taxes (continued)

 

The Company’s regular tax loss carryforwards for income tax purposes of $223,000 expire between the years 2003 and 2022. For financial reporting purposes, the Company’s regular net operating loss carryforwards are $46,000. The Company’s alternative minimum tax credit carryforward of $158,000 has no expiration date.

 

As a result of the conversion to a for-profit accident and health insurance company in 2002, the Company adjusted its deferred tax assets for temporary differences related to Empire HealthChoice Assurance, Inc’s liability for state and local taxes which resulted in the recognition of $5,374 deferred tax asset. In May 2003, the New York State Legislature enacted budget legislation that eliminates the net income portion of the New York State franchise tax applicable to every insurance company other than life insurance companies effective January 1, 2003. As a result, the Company’s tax provision for the three and six months ended June 30, 2003 was increased by $653, reflecting the reversal of the $5,374 deferred tax asset and $4,721 of franchise taxes incurred attributable to the previous three month period ended March 31, 2003.

 

5. Restructuring

 

During the second quarter of 2002, in connection with the Company’s Information Technology outsourcing agreement with IBM, the Company began the implementation of a restructuring plan relating to its information technology personnel. Certain employees were involuntarily terminated in accordance with a plan of termination, certain employees were retained by the Company and certain employees were transitioned to IBM. Severance and other costs accrued at June 30, 2002 relating to the plan of termination were $5,351. Payments related to these costs of approximately $3,196 were made through June 30, 2003. To help retain its employees and to help IBM retain its newly transitioned employees, the Company offered stay bonuses for these individuals. The estimated maximum cost of these bonuses assuming all individuals remain with the Company or IBM through the required dates, which range from 2003 to 2004, is approximately $8,518. At June 30, 2003, approximately $3,954 was accrued for these bonuses. The Company will recognize the cost of these stay bonuses in future periods as these employees provide service.

 

11


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

5. Restructuring (continued)

 

In November 2002, as part of the Company’s continuing focus on increasing overall productivity, and in part as a result of the implementation of the technology outsourcing strategy, the Company continued streamlining certain operations and adopted a plan to terminate approximately 500 employees across all segments of its business. Severance and other costs of $13,715 were accrued relating to the plan. Through June 30, 2003, payments related to these costs of $7,539 were made.

 

6. Contingencies

 

The Company is subject to a number of lawsuits, investigations and claims, some of which are class actions arising out of the conduct of its business. The Company believes that it has meritorious defenses in all of these matters and intends to vigorously defend its respective positions. The outcome of these matters is not currently predictable and the damages, if any, are also uncertain. The Company is also involved in and is subject to numerous claims, contractual disputes and uncertainties in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial condition.

 

7. Segment Information

 

WellChoice has two reportable segments: commercial managed care and other insurance products and services. The commercial managed care segment includes group preferred provider organization, or PPO, health maintenance organization, or HMO (including Medicare+Choice), exclusive provider organization, or EPO, and other products (principally dental only coverage) as well as the Company’s New York City and New York State PPO business. The New York City and New York State PPO business accounts for approximately 31% of the Company’s earned premium for the six months ended June 30, 2003.

 

The other insurance products and services segment consists of the Company’s traditional indemnity products, Medicare supplemental, individual hospital only and hospital and basic medical plans, state sponsored individual plans, government mandated individual plans and government contracts with CMS to act as a fiscal intermediary for Medicare Part A program beneficiaries and as a carrier for Medicare Part B program beneficiaries.

 

12


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

7. Segment Information (continued)

 

The reportable segments follow the Company’s method of internal reporting by products and services. Administrative expenses, investment income and other income, but not assets, are allocated to the segments. There are no intersegment sales or expenses.

 

     Commercial
Managed
Care


   Other
Insurance
Products
and
Services


   Total

Three months ended June 30, 2003

                    

Revenues from external customers

   $ 1,119,363    $ 241,247    $ 1,360,610

Investment income and net realized gains

     10,683      2,071      12,754

Other revenue

     964      183      1,147

Income from continuing operations before income tax expense

     73,354      12,082      85,436

Three months ended June 30, 2002

                    

Revenues from external customers

   $ 1,005,091    $ 298,469    $ 1,303,560

Investment income and net realized gains

     13,681      3,804      17,485

Other revenue

     503      94      597

Income from continuing operations before income tax expense

     50,957      9,135      60,092

Six months ended June 30, 2003

                    

Revenues from external customers

   $ 2,147,926    $ 488,149    $ 2,636,075

Investment income and net realized gains

     24,183      5,040      29,223

Other revenue

     1,083      208      1,291

Income from continuing operations before income tax expense

     152,003      16,416      168,419

Six months ended June 30, 2002

                    

Revenues from external customers

   $ 1,962,547    $ 591,568    $ 2,554,115

Investment income and net realized gains

     26,570      7,433      34,003

Other revenue

     10,751      2,873      13,624

Income from continuing operations before income tax expense

     120,374      19,422      139,796

 

13


Table of Contents

WellChoice, Inc. and Subsidiaries

 

Notes to Consolidated Financial Statements

(Unaudited)

(Dollars in Thousands)

 

7. Segment Information (continued)

 

The following table presents our revenue from external customers by products and services:

 

     Three months ended
June 30


   Six months ended
June 30


     2003

   2002

   2003

   2002

Revenues from external customers:

                           

Commercial managed care

                           

Premiums earned:

                           

PPO

   $ 667,824    $ 610,209    $ 1,256,732    $ 1,189,824

HMO

     302,751      285,890      596,954      561,237

EPO

     76,943      55,561      154,000      109,589

Other

     1,032      1,115      2,123      1,456

Administrative service fees

     70,813      52,316      138,117      100,441
    

  

  

  

Total commercial managed care

     1,119,363      1,005,091      2,147,926      1,962,547
    

  

  

  

Other insurance products and services:

                           

Premiums earned:

                           

Indemnity

     79,774      122,220      163,072      240,130

Individual

     118,723      128,915      240,707      257,581

Administrative service fees

     42,750      47,334      84,370      93,857
    

  

  

  

Total other insurance products and services

     241,247      298,469      488,149      591,568
    

  

  

  

Total revenues from external customers

   $ 1,360,610    $ 1,303,560    $ 2,636,075    $ 2,554,115
    

  

  

  

 

14


Table of Contents

REPORT OF INDEPENDENT ACCOUNTANTS

 

To the Board of Directors of

WellChoice, Inc.

 

We have reviewed the accompanying consolidated balance sheet of WellChoice Inc. and subsidiaries (the “Company”) as of June 30, 2003, and the related consolidated statements of income for the three-month and six-month periods ended June 30, 2003 and 2002, and the consolidated cash flows for the six-month periods ended June 30, 2003 and 2002. These financial statements are the responsibility of the Company’s management.

 

We conducted our review in accordance with the standards established by the American Institute of Certified Public Accountants. A review of interim financial information consists principally of applying analytical procedures to financial data, and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with auditing standards generally accepted in the United States, which will be performed for the full year with the objective of expressing an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

 

Based on our review, we are not aware of any material modifications that should be made to the accompanying financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States.

 

We have previously audited, in accordance with auditing standards generally accepted in the United States, the consolidated balance sheet of the Company as of December 31, 2002, and the related consolidated statements of income, stockholders’ equity and cash flows for the year then ended (not presented herein); and in our report dated February 3, 2003, we expressed an unqualified opinion on those financial statements. In our opinion the information set forth in the accompanying consolidated balance sheet as of December 31, 2002, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

 

/s/    ERNST & YOUNG LLP

 

New York, New York

July 14, 2003

 

15


Table of Contents
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis presents a review of WellChoice, Inc. and its subsidiaries (collectively, the “Company”) for the three and six months ended June 30, 2003 and 2002. This review should be read in conjunction with the consolidated financial statements and other data presented herein as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2002 on file with the Securities and Exchange Commission.

 

The statements contained in this discussion include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, or the PSLRA. When used in this Quarterly Report on Form 10-Q and in future filings by the Company with the Commission, in our press releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words or phrases “believes,” “anticipates,” “intends,” “will likely result,” “estimates,” “projects” or similar expressions are intended to identify such forward-looking statements. Any of these forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed in the forward-looking statements.

 

The discussion of risks described in “Item 1—Business” and “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2002 and the following discussion contain certain cautionary statements regarding our business that investors and others should consider. These discussions are intended to take advantage of the “safe harbor” provisions of the PSLRA. Except to the extent otherwise required by federal securities laws, in making these cautionary statements, we are not undertaking to address or update each factor in future filings or communications regarding our business or operating results, and are not undertaking to address how any of these factors may have caused results to differ from discussions or information contained in previous filings or communications. In addition, any of the matters discussed below may have affected our past, as well as current, forward-looking statements about future results. Any or all forward-looking statements in this report and in any other public statements we make may turn out to be wrong. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors discussed below will be important in determining future results. Consequently, no forward-looking statement can be guaranteed. Actual future results may vary materially from those expressed in our communications.

 

Overview

 

We are the largest health insurance company in the State of New York based on total preferred provider organization, or PPO, and health maintenance organization, or HMO, membership, which includes members under our insured and administrative services only, or self-funded, plans. We offer managed care and traditional indemnity products to approximately 4.8 million members. We have licenses with the Blue Cross Blue Shield Association which entitle us to the exclusive use of the Blue Cross and Blue Shield names and marks in ten counties in the New York City metropolitan area and in six counties in upstate New York, the non-exclusive right to use the Blue Cross and Blue Shield names and marks in one upstate New York county, the exclusive right to only the Blue Cross name and mark in seven upstate New York counties and the non-exclusive right to only the Blue Cross name in four upstate New York counties. We market our products and services using these names and marks in our New York service areas. We also market our managed care products in 16 counties in New Jersey under the WellChoice brand.

 

We offer our products and services to a broad range of customers, including large groups of more than 500 employees; middle market groups, ranging from 51 to 500 employees; small groups, ranging

 

16


Table of Contents

from two to 50 employees and individuals. Over one million of our members are covered through our national accounts, which include Fortune 500 companies.

 

Our revenue primarily consists of premiums earned and administrative service fees derived from the sale of managed care and traditional indemnity health benefits products to employer groups and individuals. Premiums are derived from insured contracts and administrative service fees are derived from self-funded contracts, under which we provide a range of customer services, including claims administration and billing and membership services. Revenue also includes administrative service fees earned under the BlueCard program for providing members covered by other Blue Cross and Blue Shield plans access to our network providers, reimbursements under our government contracts with the Centers for Medicare and Medicaid Services, or CMS, to act as a fiscal intermediary for Medicare Part A program beneficiaries and a carrier for Medicare Part B program beneficiaries, and investment income.

 

Our cost of benefits provided expense consists primarily of claims paid and claims in process and pending to physicians, hospitals and other healthcare providers and includes an estimate of amounts incurred but not yet reported. These costs include payments to primary care physicians, specialists, hospitals, pharmacies, outpatient care facilities and the costs associated with managing the extent of such care. Administrative expenses consist primarily of compensation expenses, commission payments to brokers and other general business expenses.

 

We report our operating results as two business segments: commercial managed care and other insurance products and services. Our commercial managed care segment accounted for 85.0% of our membership as of June 30, 2003. Our commercial managed care segment includes group PPO, HMO (including Medicare+Choice, which accounted for 9.6% of premium earned for the six months ended June 30, 2003), EPO, and other products (principally dental-only coverage) as well as our PPO business under our accounts with New York City and New York State. Our other insurance products and services segment consists of our indemnity and individual products. Our indemnity products include traditional indemnity products and government contracts with CMS to act as a fiscal intermediary and carrier. Our individual products include Medicare supplemental, state sponsored plans, government mandated individual plans and individual hospital-only and hospital and basic medical plans. We allocate administrative expenses, investment income and other income, but not assets, to our segments. Except when otherwise specifically stated or where the context requires, all references in this document to our membership include both our insured and self-funded membership. Our New York City and New York State account members are covered under insured plans.

 

Our future results of operations will depend in part on our ability to predict and control health care costs through underwriting criteria, utilization management, product design and negotiation of favorable provider and hospital contracts. Our ability to contain such costs may be adversely affected by changes in utilization rates, demographic characteristics, the regulatory environment, health care practices, inflation, new technologies, clusters of high-cost cases, continued consolidation of physician, hospital and other provider groups, acts of terrorism and bioterrorism or other catastrophes, including war, and numerous other factors. In addition, the regional concentration of our business may subject us to economic downturns in New York State and, in particular, the New York City metropolitan area. The inability to mitigate any or all of the above-listed or other factors may adversely affect our future profitability.

 

The Conversion; Additional State and Local Taxes

 

In November 2002, our principal insurance subsidiary, “HealthChoice,” converted to for-profit status, which resulted in WellChoice becoming the publicly-traded parent company for that subsidiary and our other operating subsidiaries. We refer to the post-conversion HealthChoice as “Empire.” As a

 

17


Table of Contents

result of the conversion, we became a for-profit entity and are subject to New York state and local taxes that we were not previously required to pay. These include premium taxes on most non-HMO insured business and sales and use taxes (which are recorded as administrative expenses), as well as state and local income taxes.

 

Recent Developments

 

POS Product Launch. Consistent with our strategy to offer a broad continuum of managed care products in the New York market, during the second quarter of 2003, we launched a point of service, or POS, product to employer groups, focused primarily on small and middle market customers. The product, Direct POS, provides members with the ability to utilize services on an in or out of network basis. Our POS product has similar features to our Direct HMO product that permits members to access out-of-network specialists without a referral, and also allows members to access out-of-network providers in return for deductibles and/or co-insurance. We believe the POS product will complement our existing managed care product portfolio by offering employers an additional product within our family of managed care products to meet the needs of their employees. Our ability to successfully launch this product will depend in part upon our use of brokers in placing business with small and middle market accounts and expect that it may take several quarters for brokers to gain familiarity with this product offering.

 

New York State Budget Legislation. In May 2003, the New York State Legislature enacted budget legislation that directly impacts us. Specifically, the new law contains the following provisions:

 

    an increase, retroactive to January 1, 2003, in the premium tax rate for accident and health insurers to 1.75% from 1%, while eliminating the net income portion of the New York State franchise tax applicable to every insurance company other than life insurance companies;

 

    an increase, effective July 1, 2003, in the assessment on an insurer, HMO or self-funded plan for hospital bad debts and charity care under the Health Care Reform Act to 8.85% from 8.18% of hospital claims;

 

    a 5% increase, effective January 1, 2004, in the monthly per covered life assessment on an insurer, HMO or self-funded plan which reimburses hospitals for graduate medical care education expenses;

 

    an increase, effective June 1, 2003, in the combined New York State and New York City sales tax rate from 8.25% to 8.65%.

 

During the six months ended June 30, 2003, the impact of the enacted legislation related to the increase in premium tax and the elimination of the income tax was to reduce our net income by approximately $5.2 million, or $0.06 per share. This impact was principally due to the reversal of deferred tax assets for temporary differences relating to our liability for state and local income taxes. The foregoing gives effect to the recoupment of the additional premium tax on the premiums charged to certain customers. Based on current membership data, we estimate the annualized impact of the increase in the assessment for bad debt and charity and the covered life assessment related to graduate medical expense would reduce our net income by approximately $1.8 million and $1.0 million, respectively. The foregoing gives effect to the recoupment of these additional expenses on the premiums charged to certain customers. We do not expect the impact of the enacted legislation related to the increase in sales tax to have a material impact on our financial statements.

 

18


Table of Contents

While we intend to mitigate or cover the effects of the increased costs resulting from the New York State budget legislation through, among other things, increased premiums, we may not be successful in whole or in part from those efforts. Moreover, our existing insured accounts could migrate to self-insured accounts where the administrative service fee revenues we receive from those customers are not subject to premium tax.

 

As a result of the elimination of the net income portion of the New York State franchise tax applicable to our New York accident and health insurance subsidiary, we expect to incur federal, state and local income taxes at the rate of approximately 40% of pre-tax net income.

 

Critical Accounting Policies and Estimates

 

The following is an explanation of our accounting policies considered most significant by management. These accounting policies require us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information is known. Actual results could differ materially from those estimates.

 

Revenue Recognition

 

Our membership contracts generally have one year terms and are subject to cancellation upon 60 days written notice. Premiums are generally due monthly and are recognized as revenue during the period in which we are obligated to provide services to our members. We record premiums received prior to such periods as unearned premiums. We record premiums earned net of an allowance for doubtful accounts. Premiums recorded for groups with certain funding arrangements are based upon the actual and estimated claims experience of these groups. Future adjustments to the claims experience of these groups will result in changes in premium revenue. Our estimated claim experience is based on a number of factors, including prior claims experience. These estimates are continually reviewed and adjusted based on actual claims experience. Any changes in these estimates are included in current period results. Funds received from these groups in excess of premiums recorded are reflected as liabilities on our balance sheet.

 

We recognize administrative service fees during the period the related services are performed. Administrative service fees consist of revenues from the performance of administrative services for self-funded contracts, reimbursements from our contracts with CMS under which we serve as an intermediary for the Medicare Part A program and a carrier for the Medicare Part B program, and fees earned under the BlueCard program. The revenue earned under our contracts with CMS is recorded net of an allowance for an estimate of disallowed expenses.

 

Cost of Benefits Provided

 

Cost of benefits provided includes claims paid, claims in process and pending, and an estimate for unreported claims for charges for healthcare services for enrolled members during the period. These costs include payments to primary care physicians, specialists, hospitals, pharmacies, outpatient care facilities and the costs associated with managing the extent of such care. Costs of benefits are reported net of pharmacy rebates, coordination of benefits and pool recoveries.

 

We are required to estimate the total amount of claims that have not been reported or that have been received, but not yet adjudicated, during any accounting period. These estimates, referred to as unpaid claims on our balance sheet, are recorded as liabilities.

 

19


Table of Contents

We estimate claim reserves in accordance with Actuarial Standards of Practice promulgated by the Actuarial Standards Board, the committee of the American Academy of Actuaries that establishes the professional guidelines and standards for actuaries to follow. A degree of judgment is involved in estimating reserves. We make assumptions regarding the propriety of using existing claims data as the basis for projecting future payments. Factors we consider include medical cost trends, the mix of products and benefits sold, internal processing changes and the amount of time it took to pay all of the benefits for claims from prior periods. To the extent the actual amount of these claims is greater than the estimated amount based on our underlying assumptions, such differences would be recorded as additional cost of benefits provided in subsequent accounting periods and our future earnings would be adversely affected. To the extent the claims experience is less than estimated based on our underlying assumptions, such differences would be recorded as a reduction in cost of benefits provided in subsequent accounting periods.

 

Management believes that the amount of unpaid claims is adequate to cover our ultimate liability for unpaid claims as of June 30, 2003. Actual claim payments and other items, however, may differ from established estimates. Assuming a hypothetical 1% difference between our June 30, 2003 estimates of unpaid claims and actual claims payable for prospectively rated business, net income for the three months ended June 30, 2003, would increase or decrease by approximately $1.5 million and earnings per share would increase or decrease by approximately $0.02 per share.

 

Taxes

 

We account for income taxes using the liability method. Accordingly, deferred tax assets and liabilities are recognized for the future tax consequences attributable to the difference between the financial reporting and tax basis of assets and liabilities. We record a valuation allowance to reduce our deferred tax asset to the amount we believe is more likely than not to be realized. This determination, which requires considerable judgment, is based on a number of assumptions including an estimate of future taxable income. If future taxable income or other factors are not consistent with our expectations, an adjustment to our deferred tax asset may be required in the future. Any such adjustment would be charged or credited to income in the period such determination was made.

 

20


Table of Contents

Selected Membership Data and Results of Operations

 

The following table sets forth selected membership data as of the dates set forth below:

 

     June 30,

(members in thousands)    2003

   2002

Products and services:

         

Commercial managed care:

         

Group PPO, HMO, EPO and other(1)(2)

   2,275    1,903

New York City and New York State PPO

   1,803    1,782
    
  

Total commercial managed care

   4,078    3,685
    
  

Other insurance products and services:

         

Indemnity

   492    707

Individual

   227    252
    
  

Total other insurance products and services

   719    959
    
  

Overall total

   4,797    4,644
    
  

Customers:

         

Large group

   2,921    2,907

Small group and middle market

   419    406

Individuals

   278    309

National accounts

   1,179    1,022
    
  

Overall total

   4,797    4,644
    
  

Funding type:

         

Commercial managed care:

         

Insured

   2,618    2,626

Self-funded

   1,460    1,059
    
  

Total commercial managed care

   4,078    3,685
    
  

Other insurance products and services:

         

Insured

   438    616

Self-funded

   281    343
    
  

Total other insurance products and services

   719    959
    
  

Overall total

   4,797    4,644
    
  

(1)   Our HMO product includes Medicare+Choice. As of June 30, 2003 and 2002, we had approximately 52,000, and 57,000 members, respectively, enrolled in Medicare+Choice.
(2)   “Other” principally consists of our members enrolled in dental only coverage.

 

As of June 30, 2003, total enrollment was 4.8 million members, of which, commercial managed care enrollment was 4.1 million members or 85.0% of total enrollment. Total enrollment and commercial managed care enrollment increased 3.3% and 10.7%, respectively, from June 30, 2002 to June 30, 2003. Our enrollment growth of 19.5%, or 372,000 members, in group PPO, HMO, EPO and other was

 

21


Table of Contents

primarily due to a combination of new membership in national customer accounts in our PPO and EPO products and the migration of members enrolled in our indemnity products to our commercial managed care products. Enrollment in other insurance products and services declined 25.0% or approximately 240,000 members to approximately 700,000 members due, in part, to the continued migration of members to commercial managed care products. The migration of fully-insured business to self-funded business as well as new self-funded business resulted in a 5.7% decrease in fully-insured business and a 24.2% increase in self-funded business. The migration to self-funded business is most noticeable in large group PPO and indemnity products. New self-funded national account business accounted for 144,000 new members.

 

As of June 30, 2003, our New York State account covered approximately 989,000 members, or 20.6% of our total membership and 24.3% of our commercial managed care membership, and our New York City account covered approximately 814,000 members, or 17.0% of our total membership and 20.0% of our commercial managed care membership. The pricing of our products provided to New York State and New York City have historically been renegotiated annually. Effective January 1, 2003, we agreed to new pricing with New York State covering a three-year period through December 31, 2005, though both parties retain the right to terminate the contract on six months’ notice. For more than a year, the New York City account has been subject to a competitive bid process that is open to us and to third parties and involves renegotiation with respect to rates. We had rates in place initially through December 31, 2002 and then new rates were negotiated for the first six months of 2003, with respect to our PPO product with the New York City. The contract awarded to the winner of the competitive bid process had been expected to commence July 1, 2003, but has been delayed. We are in the process of negotiating rates that would apply subsequent to June 30, 2003. The loss of one or both of the New York City and New York State accounts would result in reduced membership and revenue and require us to reduce, reallocate or absorb administrative expenses associated with these accounts.

 

22


Table of Contents

The following table sets forth results of operations for each of our segments for the periods set forth below:

 

     Three months ended
June 30,


    Six months ended
June 30,


 
     2003

    2002

    2003

    2002

 
     ($ in millions)  

Commercial Managed Care:

                                

Total revenue

   $ 1,131.0     $ 1,019.2     $ 2,173.2     $ 1,999.8  

Income from continuing operations before income tax expense

   $ 73.4     $ 50.9     $ 152.0     $ 120.4  

Medical loss ratio (1):

                                

Commercial managed care total

     86.2 %     87.4 %     85.8 %     87.3 %

Commercial managed care, excluding New York City and New York State PPO(2)

     82.1 %     83.4 %     82.0 %     83.5 %

Administrative expense ratio (3)

     13.7 %     13.5 %     13.8 %     12.9 %

Administrative expense ratio - premium equivalent basis (4)

     8.9 %     9.6 %     9.1 %     9.3 %

Other Insurance Products and Services:

                                

Total revenue

   $ 243.5     $ 302.4     $ 493.4     $ 601.9  

Income from continuing operations before income tax expense

   $ 12.0     $ 9.2     $ 16.4     $ 19.4  

Medical loss ratio (1)

     83.5 %     86.1 %     85.2 %     86.6 %

Administrative expense ratio (3)

     27.3 %     25.8 %     27.2 %     25.6 %

Administrative expense ratio - premium equivalent basis (4)

     17.6 %     16.8 %     17.4 %     16.5 %

(1)   Medical loss ratio represents cost of benefits provided as a percentage of premiums earned.
(2)   We present commercial managed care medical loss ratio, excluding New York City and New York State PPO because these accounts differ from our standard PPO product in that they are hospital-only accounts which have lower premiums relative to administrative expense and are retrospectively rated with a guaranteed administrative service fee. In addition, the size of these accounts distorts our performance when the total medical loss ratios are presented.
(3)   Administrative expense ratio represents administrative and conversion and IPO expenses as a percentage of premiums earned and administrative service fees.
(4)   Premium equivalents is the sum of premium earned, administrative service fees and the amount of paid claims attributable to our self-funded health business pursuant to which we provide a range of customer services, including claims administration and billing and membership services. The following table sets forth our premium equivalent calculation:

 

     Three months ended
June 30,


   Six months ended
June 30,


     2003

   2002

   2003

   2002

     ($ in millions)

Commercial Managed Care:

                           

Premiums earned

   $ 1,048.5    $ 952.8    $ 2,009.8    $ 1,862.1

Administrative service fees

     70.8      52.3      138.1      100.4

Claims paid for our self-funded health business

     606.7      409.5      1,103.1      757.3
    

  

  

  

Premium equivalents

   $ 1,726.0    $ 1,414.6    $ 3,251.0    $ 2,719.8

 

23


Table of Contents

Other Insurance Products and Services

                           

Premiums earned

   $ 198.5    $ 251.1    $ 403.8    $ 497.7

Administrative service fees

     42.8      47.4      84.4      93.9

Claims paid for our self-funded health business

     132.2      159.8      274.8      329.1
    

  

  

  

Premium equivalents

   $ 373.5    $ 458.3    $ 763.0    $ 920.7

 

Administrative expense ratio—premium equivalent basis is determined by dividing administrative and conversion and IPO expenses by premium equivalents for the relevant periods. We present the administrative expense ratio on a premium equivalent basis because that ratio enables us to measure administrative expenses relative to the entire volume of insured and self-funded business serviced by us and is commonly used in the health insurance industry and by investors to compare operating efficiency among companies.

 

Three Months Ended June 30, 2003 Compared to Three Months Ended June 30, 2002

 

Total revenue increased 4.0%, or $52.9 million, to $1,374.5 million for the three months ended June 30, 2003, from $1,321.6 million for the three months ended June 30, 2002 primarily due to an increase in premium and administrative service fee revenue, offset by a decrease in investment income.

 

Premium revenue increased $43.1 million, or 3.6%, to $1,247.0 million for the three months ended June 30, 2003, from $1,203.9 million for the three months ended June 30, 2002. The increase in premium revenue was primarily due to growth in our commercial managed care segment. Commercial managed care premium revenue was $1,048.5 million for the three months ended June 30, 2003, a 10.0% increase compared to the three months ended June 30, 2002. The increase in commercial managed care premium revenue was attributable to increased cost of benefits provided on our retrospectively rated contracts, rate increases and membership growth in our EPO products. Premium revenue growth was partially offset by the anticipated decline in our other insurance products and services enrollment and the migration of insured large group PPO and indemnity contracts to self-funded contracts. On a per member per month, or PMPM basis, premium for the three months ended June 30, 2003 increased 11.0%, to $139.60 from $125.80 for the three months ended June 30, 2002. Commercial managed care PMPM premium increased to $135.84 for the three months ended June 30, 2003, from $123.17 for the three months ended June 30, 2002. Excluding the New York City and New York State PPO, commercial managed care PMPM premium increased to $274.90 for the three months ended June 30, 2003, compared to $251.43 for the three months ended June 30, 2002.

 

Administrative service fee revenue increased 13.9%, or $13.9 million, to $113.6 million for the three months ended June 30, 2003, from $99.7 million for the three months ended June 30, 2002. The increase was primarily due to growth in self-funded commercial managed care membership and increased BlueCard fees. Approximately $14.2 million of the increase was driven by the migration of approximately 191,000 insured large group indemnity members to self-funded contracts and approximately 144,000 members from new national account customers, offset in part by a 18.1% decrease in self-funded indemnity membership. Total BlueCard fees increased 13.4% or $1.6 million, to $13.5 million for the three months ended June 30, 2003, from $11.9 million for the three months ended June 30, 2002 due to an increase in transaction volume.

 

Investment income, net of investment expenses, which consists predominantly of interest and dividend income, decreased 34.8%, or $6.2 million, to $11.6 million for the three months ended June 30, 2003, from $17.8 million for the three months ended June 30, 2002 due to lower interest rates. Net realized gains of $1.2 million for the three months ended June 30, 2003 was primarily the result of net gains on the sale of corporate bonds and a net increase in the market value of warrants classified on our

 

24


Table of Contents

balance sheet as other long-term equity investments. There were no investment transactions that resulted in significant gains or losses for the three months ended June 30, 2002.

 

Other income, net of $1.1 million for the three months ended June 30, 2003, increased $0.6 million from $0.5 million for the three months ended June 30, 2002, due to non–recurring transactions during 2003. Non-recurring transactions for the three months ended June 30, 2003 included administrative service fees of $0.5 million related to certain claim recovery efforts and $0.3 million of proceeds received from a bankruptcy settlement involving a previously owned common stock investment.

 

Total cost of benefits provided increased 2.0%, or $21.2 million, to $1,069.8 million for the three months ended June 30, 2003, from $1,048.6 million for the three months ended June 30, 2002. Overall, benefit expense on a PMPM basis for the three months ended June 30, 2003 increased to $119.75, from $109.57 for the three months ended June 30, 2002. This reflects a 9.3% increase in costs of benefits provided on a PMPM basis, offset by a 6.7% decline in member months due to the migration of membership from fully-insured to self-funded contracts. The increase in benefit costs was due to increases in unit costs for drug and facility claims as well as increases in utilization for outpatient claims. Commercial managed care PMPM benefit expense increased 8.8% to $117.13 for the three months ended June 30, 2003, from $107.62 for the three months ended June 30, 2002. Costs of benefits provided in our other insurance products and services segment for the three months ended June 30, 2003 increased 15.8%, on a PMPM basis, to $136.42 from $117.84 for the three months ended June 30, 2002. This reflects the impact of the migration of certain low-cost indemnity plans to self-funded arrangements and claim credits reported in 2002 resulting from a litigation settlement.

 

The total medical loss ratio decreased to 85.8% for the three months ended June 30, 2003, from 87.1% for the three months ended June 30, 2002, resulting from an 11.0% increase in average premium yield, which is the change in PMPM premium, offset by, a 9.3% increase in PMPM benefit expense. Cost of benefits provided for the three months ended June 30, 2003 and 2002 included $12.4 million and $33.3 million, respectively, of favorable prior period reserve development on prospectively rated business. The medical loss ratio in our commercial managed care segment decreased to 86.2% for the three months ended June 30, 2003, from 87.4% for the three months ended June 30, 2002. Excluding the New York City and New York State PPO accounts (see note 2 to the table on page 22 of this report), the medical loss ratio in our commercial managed care segment decreased to 82.1% for the three months ended June 30, 2003, from 83.4% for the three months ended June 30, 2002, reflecting a 9.3% increase in PMPM premiums, offset by a 7.5% increase in PMPM benefit expense. The medical loss ratio for other insurance products and services decreased to 83.5% for the three months ended June 30, 2003, from 86.1% for the three months ended June 30, 2002.

 

Administrative expenses increased 4.6%, or $9.7 million, to $219.3 million for the three months ended June 30, 2003, from $209.6 million for the three months ended June 30, 2002. This increase was primarily attributable to increased premium and sales and use taxes of $25.4 million, resulting from our change in tax status due to our for-profit conversion, increased professional fees of $8.7 million due to HIPAA compliance consulting and our IBM outsourcing agreement, and increased corporate insurance policy expense of $2.9 million, offset in part by a decrease in compensation expense of approximately $15.0 million from reduced staffing levels, decreased severance expense and legal fees of $5.6 million, as the prior year expense included the severance accruals and non-recurring legal fees related to the IBM outsourcing agreement, and a $3.0 million decrease in marketing expense. Conversion and IPO expenses of $3.3 million were incurred during the three months ended June 30, 2002. Our administrative expense ratio was 16.1% for the three months ended June 30, 2003.

 

In September 2003, we will begin transitioning from several leased properties, which temporarily replaced our World Trade Center office, to a long-term leased facility. During the transition period (September through December 2003), we will incur occupancy related expenses for both our temporary

 

25


Table of Contents

leased facilities and our long-term leased facility. As a result, we will incur approximately $3.0 million in incremental facility costs during the transition. In addition, in 2003 we estimate that we will incur $1.3 million and $6.6 million in depreciation and start-up costs, respectively, related to our long-term leased facility.

 

Income from continuing operations before income taxes increased 42.1%, or $25.3 million, to $85.4 million for the three months ended June 30, 2003, from $60.1 million for the three months ended June 30, 2002. This improvement was primarily driven by increased self-funded commercial managed care membership and improved underwriting performance. The income tax expense of $36.6 million reduced income from continuing operations and net income to $48.8 million for the three months ended June 30, 2003. We did not incur any material income tax expense for the three months ended June 30, 2002 due to our not-for-profit status at that time.

 

Six Months Ended June 30, 2003 Compared to Six Months Ended June 30, 2002

 

Total revenue increased 2.5%, or $64.9 million, to $2,666.6 million for the six months ended June 30, 2003, from $2,601.7 million for the six months ended June 30, 2002 primarily due to an increase in premium and administrative service fee revenue, offset by decreases in investment and other income.

 

Premium revenue increased $53.8 million, or 2.3%, to $2,413.6 million for the six months ended June 30, 2003, from $2,359.8 million for the six months ended June 30, 2002. The increase in premium revenue was primarily due to growth in our commercial managed care segment. Commercial managed care premium revenue was $2,009.8 million for the six months ended June 30, 2003, a 7.9% increase compared to the six months ended June 30, 2002. The increase in commercial managed care premium revenue was attributable to increased cost of benefits provided on our retrospectively rated contracts, rate increases, and membership growth in our small group and middle market PPO and EPO customers and large group EPO customers. Premium revenue growth was partially offset by the anticipated decline in our other insurance products and services enrollment and the migration of insured large group PPO and indemnity contracts to self-funded contracts. On a per member per month, or PMPM basis, premium for the six months ended June 30, 2003 increased 9.6%, to $134.86, from $123.06 for the six months ended June 30, 2002. Commercial managed care PMPM premium increased to $130.12 for the six months ended June 30, 2003, from $120.64 for the six months ended June 30, 2002. Excluding the New York City and New York State PPO, commercial managed care PMPM premium increased to $271.47 for the six months ended June 30, 2003, compared to $247.02 for the six months ended June 30, 2002.

 

Administrative service fee revenue increased 14.5%, or $28.2 million, to $222.5 million for the six months ended June 30, 2003, from $194.3 million for the six months ended June 30, 2002. The increase was primarily due to growth in self-funded commercial managed care membership and increased BlueCard fees, offset in part by lower administrative expenses attributable to our CMS contract for Medicare Part A and Part B programs. Approximately $29.6 million of the increase was a result of the migration of 191,000 approximately insured large group indemnity contracts to self-funded contracts and approximately 144,000 members from new national account customers, offset in part by a 18.1% decrease in self-funded indemnity membership. Total BlueCard fees increased 14.9% or $3.2 million, to $24.7 million for the six months ended June 30, 2003, from $21.5 million for the six months ended June 30, 2002 due to an increase in transaction volume.

 

Investment income, net of investment expenses, which consists predominantly of interest and dividend income, decreased 27.6%, or $9.5 million, to $24.9 million for the six months ended June 30, 2003, from $34.4 million for the six months ended June 30, 2002 due to lower interest rates. Net realized gains of $4.3 million for the six months ended June 30, 2003 were primarily the result of net gains on government and corporate bond sales and a net increase in the market value of warrants classified in our

 

26


Table of Contents

balance sheet as other long-term equity investments. There were no investment transactions that resulted in significant gains or losses for the six months ended June 30, 2002.

 

Other income, net of $1.3 million for the six months ended June 30, 2003, decreased $12.3 million from $13.6 million for the six months ended June 30, 2002, due to non–recurring transactions during 2002. Specifically, the six months ended June 30, 2002 included a gain of $8.0 million resulting from insurance settlements in excess of estimated recoveries recorded as of December 31, 2001 for property and equipment lost at our World Trade Center headquarters, interest earned on advances to hospitals of $2.4 million and interest received on outstanding hospital advances previously considered uncollectible of $1.9 million.

 

Total cost of benefits provided increased 0.6%, or $12.0 million, to $2,069.0 million for the six months ended June 30, 2003, from $2,057.0 million for the six months ended June 30, 2002, This reflects a 7.8% increase in costs of benefits provided on a PMPM basis, offset by a 6.7% decline in member months due to the migration of membership from fully-insured to self-funded contracts. The increase in benefit costs was due to increases in unit costs for drug and facility claims as well as increases in utilization for outpatient claims. Overall, benefit expense on a PMPM basis for the six months ended June 30, 2003 increased to $115.60, from $107.27 for the six months ended June 30, 2002. Commercial managed care PMPM benefit expense increased 6.0% to $111.68 for the six months ended June 30, 2003, from $105.35 for the six months ended June 30, 2002. Costs of benefits provided in our other insurance products and services segment for the six months ended June 30, 2003 increased 21.8%, on a PMPM basis, to $140.30 from $115.19 for the six months ended June 30, 2002. As described above, this also reflects the net impact of the migration of certain low-cost indemnity plans to self-funded arrangements and claim credits reported in 2002 resulting from a litigation settlement.

 

The total medical loss ratio decreased to 85.7% for the six months ended June 30, 2003, from 87.2% for the six months ended June 30, 2002, resulting from a 9.6% increase in average premium yield, which is the change in PMPM premium, offset by a 7.8% increase in PMPM benefit expense. Cost of benefits provided for the six months ended June 30, 2003 and 2002 included $1.3 million and $32.1 million, respectively, of favorable prior period reserve development on prospectively rated business. The medical loss ratio in our commercial managed care segment decreased to 85.8% for the six months ended June 30, 2003, from 87.3% for the six months ended June 30, 2002. Excluding the New York City and New York State PPO accounts (see note 2 to the table on page 22 of this report), the medical loss ratio in our commercial managed care segment decreased to 82.0% for the six months ended June 30, 2003, from 83.5% for the six months ended June 30, 2002, reflecting a 9.9% increase in PMPM premiums, offset by a 8.0% increase in PMPM benefit expense, lead by improvement in Medicare+Choice. The medical loss ratio for other insurance products and services decreased to 85.2% for the six months ended June 30, 2003, from 86.6% for the six months ended June 30, 2002.

 

Administrative expenses increased 7.0%, or $27.9 million, to $429.2 million for the six months ended June 30, 2003, from $401.3 million for the six months ended June 30, 2002. This increase was primarily attributable to increased premium and sales and use taxes of $35.4 million, resulting from our change in tax status due to our for-profit conversion, increased professional fees of $21.1 million as a result of the IBM outsourcing agreement and increased corporate insurance policy expense of $6.0 million, offset in part by a decrease in compensation expense due to a reduction of staffing levels of approximately $25.6 million and decreased marketing expense of $3.5 million. Conversion and IPO expenses of $3.6 million were incurred during the six months ended June 30, 2002. Our administrative expense ratio was 16.3% for the six months ended June 30, 2003. We expect this ratio to range between 16.5% and 17.0% for the balance of 2003.

 

Income from continuing operations before income taxes increased 20.5%, or $28.6 million, to $168.4 million for the six months ended June 30, 2003, from $139.8 million for the six months ended June 30, 2002. This improvement was primarily driven by increased self-funded commercial managed

 

27


Table of Contents

care membership and improved underwriting performance. The income tax expense of $71.9 million reduced income from continuing operations and net income to $96.5 million for the six months ended June 30, 2003. We did not incur any material income tax expense for the six months ended June 30, 2002 due to our not-for-profit status at that time. Taking into account our loss from discontinued operations during 2002, our net income for the six months ended June 30, 2002 was $138.7 million.

 

Liquidity and Capital Resources

 

WellChoice is a holding company and depends on its subsidiaries for cash and working capital to pay expenses. WellChoice receives cash from its subsidiaries from administrative and management service fees, as well as tax sharing payments and dividends. On June 17, 2003, the Superintendent approved the payment of a dividend to WellChoice from Empire in the amount of $140 million, which was paid on June 30, 2003. Dividends paid to WellChoice from its subsidiaries, in 2002 totaled $225.0 million. These dividends have been accounted for as an equity transfer from a subsidiary to the parent of a consolidated group. In 2002, we received net proceeds of approximately $28.0 million, after deducting the underwriting discount from the exercise of the underwriters’ over-allotment option in our initial public offering. We used these proceeds from the exercise of the over-allotment option to pay offering and conversion expenses and for general corporate purposes.

 

“Free cash” at the parent holding company at June 30, 2003 was $319.6 million. “Free cash” at the parent holding company is derived from the stand-alone balance sheet of WellChoice, Inc. and is calculated as follows: cash and cash equivalents plus marketable securities less accounts payable and accrued expenses, managed cash overdrafts and amounts due to/from subsidiaries.

 

Our subsidiaries’ primary source of cash is from premiums and fees received and investment income. The primary uses of cash include healthcare benefit expenses, brokers’ and agents’ commissions and administrative expenses. We generally receive premium revenues in advance of anticipated claims for related healthcare services.

 

Our investment policies are designed to provide liquidity to meet anticipated payment obligations and to preserve principal. We believe the composition of our marketable investment portfolio is conservative, consisting primarily of high-rated, fixed income securities with the objective of producing a consistently growing income stream and maximizing risk-adjusted total return. The fixed income portfolio is comprised of U.S. government securities, corporate bonds, asset-backed bonds and mortgage-related securities. The average credit rating of our fixed income portfolio as of June 30, 2003 was “AA.” A portion of the fixed income portfolio is designated as short-term and is intended to cover near-term cash flow needs. Our marketable equity portfolio as of June 30, 2003 consisted of an investment in a mutual fund indexed to the S&P 500, our common stock investment in WebMD, our investment in non-redeemable preferred stock of several companies and equity investments held in our nonqualified deferred compensation plans. As of June 30, 2003 and December 31, 2002, our marketable equity portfolio was 5.9% of the total marketable investment portfolio.

 

On October 17, 2002, we entered into a credit and guaranty agreement, effective as of November 7, 2002, with The Bank of New York, as Issuing Bank and Administrative Agent, and several other financial institutions as agents and lenders, which will provide us with a credit facility. We are able to borrow under the credit facility for general working capital purposes. The total outstanding amounts under the credit facility cannot exceed $100.0 million. The facility has a term of 364 days, subject to extension for additional periods of 364 days with the consent of the lenders. Borrowings under the facility will bear interest, at our option, at The Bank of New York’s prime commercial rate (or, if greater, 0.50% plus the federal funds rate) as in effect from time to time plus a margin of between zero and 1.0%, or

 

28


Table of Contents

LIBOR plus a margin of between 1.125% and 2.250%, with the applicable margin to be determined based on our financial strength rating. As of June 30, 2003, there were no funds drawn against this line of credit.

 

The credit facility contains covenants that limit our ability to issue any equity interest which is not issued on a perpetual basis or in respect of which we shall become liable to purchase, redeem, retire or otherwise acquire any such interest, including any class of redeemable preferred stock. However, the credit facility does not restrict us from paying dividends on our common stock or repurchasing or redeeming shares of our common stock. Covenants under the credit facility also impose limitations on the incurrence of secured debt, creation of liens, mergers, asset sales, transactions with affiliates and material amendments of material agreements, as defined in the credit facility without the consent of the lenders. In addition, the credit facility contains certain financial covenants. Failure to comply with any of these covenants will result in an event of default, which could result in the termination of the credit facility.

 

The ability of our insurance and HMO subsidiaries to pay dividends to us is subject to regulatory requirements, including state insurance laws and health department regulations and regulatory surplus or admitted asset requirements, respectively. These laws and regulations require the approval of the applicable state insurance department or health regulators in order to pay any proposed dividend over a certain amount. For example, any proposed dividend to WellChoice from Empire, which, together with other dividends paid within the preceding twelve month period, exceeds the lesser of 10% of its surplus to policyholders or 100% of adjusted net investment income will be subject to approval by the New York Department of Insurance. The provisions of our Blue Cross and Blue Shield licenses also may limit our ability to obtain dividends or other cash payments from our subsidiaries as they require our licensed subsidiaries to retain certain levels of minimum surplus and liquidity.

 

We believe that cash flow from our operations and our cash and investment balances, including the proceeds of the dividend mentioned above, will be sufficient to fund continuing operations and capital expenditures for at least the next twelve months.

 

Six months ended June 30, 2003 compared to six months ended June 30, 2002

 

Cash from operating activities increased $100.8 million to $104.2 million for the six months ended June 30, 2003, from $3.4 million for the six months ended June 30, 2002. The increase in cash from operating activities is principally due to increased income from continuing operations before income taxes, a return of advance premium held related to our New York State account of $36.3 compared to a $56.9 million return of advanced premium for the six months ended June 30, 2002, a decrease of federal, state and local income taxes paid of $19.5 million due primarily to the third quarter 2001 federal income tax payment being made in 2002 as a result of an extension granted due to the attack on the World Trade Center, increased group and other contract liabilities of $24.3 million and increased accrued expenses of $13.8 million, due to the timing of cash disbursements for administrative expenses.

 

Net cash provided by investing activities of $242.6 million for the six months ended June 30, 2003, compared to cash used in investment activities of $36.9 million for the six months ended June 30, 2002, resulted primarily from the sale of investments exceeded purchases as a result of bonds in our investment portfolio being called due to declining interest rates. Cash received for these bonds was reinvested in cash equivalents. Fixed asset purchases for the six months ended June 30, 2003 were $10.5 million, of which $4.9 million was spent on capital expenditures to prepare our Brooklyn, New York facility for occupancy beginning September, 2003. Fixed asset purchases for the six months ended June 30, 2002 were $15.5 million, of which $2.0 million was spent on capital expenditures to prepare our Brooklyn, New York facility for occupancy beginning September, 2003. We anticipate that we will incur total leasehold improvement costs and related capital expenditures of approximately $47.5 million through the year ending December 31, 2003. These expenditures will be funded using internal cash.

 

29


Table of Contents

Net cash used in financing activities of $1.5 million and $1.2 million for the six months ended June 30, 2003 and 2002, respectively, reflects payments for capital lease obligations.

 

Market Stabilization Pools

 

The New York State Community Rating Law (the “Law”) requires insurers and HMOs writing small employer (groups with less than 50 eligible employees) and individual (non-group) business to participate in certain market stabilization pools (“Pools”). Under the Law there are two major Pools: a pool for individual and small group contracts excluding Medicare Supplemental contracts (“non Med Supp Pool”) and a pool for Medicare Supplemental contracts (“Med Supp Pool”). Both Pools operate on a calendar year basis.

 

For pool years prior to 1996, payments to and from the Pools were based on demographic data submitted by insurers. The non Med Supp Pool also contained a component that reimbursed insurers for a portion of claim costs related to certain specified medical conditions (“SMC”). Effective January 1, 1996, the Law was amended. The new law changed the pooling mechanism from one based on demographics and SMC to a method based on the experience for approximately fifty medical markers on medical conditions.

 

The revised Law required that the demographic and SMC approach be phased out over a four year period. The revised methodology is complex and, as a result, implementing regulations were not issued until 2002. During this period, an interim method to distribute the portion of the Pools based on the new methodology for non-Med Supp Pool funds was developed for pool years 1996 through 1998. Also during this time, the New York State Insurance Department (“the Department”) determined that the demographic approach was permissible under the 1996 law and would continue to be the method used for the Med Supp Pool. To date, distributions for the portion of the Pools based on the new methodology have been made through pool year 1998 from the non-Med Supp Pool, and through pool year 1996 from the Med Supp Pool.

 

As of June 30, 2003, we have not established a receivable or payable for non Med Supp Pool years 1999 through 2003 and Med Supp Pool years 1997 through 1999, due to the general uncertainty surrounding the ultimate disposition of payments to or receipts from the Pools and the lack of data necessary to appropriately estimate such amounts. Our ultimate payment to or receipts from these Pools may have a material impact to our financial statements.

 

In June 2003, we received the data necessary to establish receivables for Med Supp Pool years 2000, 2001, 2002 and for the six months ended June 30, 2003 and as a result, recorded receivables of $12.6 million, $12.8 million, $12.8 million and $4.8 million, respectively. Additionally, we recorded a liability for premium refunds of $1.3 million for the first half of 2003. For the six months ended June 30, 2003, cost of benefits included claim credits of $4.8 million and revenue reflects a premium reduction of $1.3 million for Med Supp Pool year 2003. We believe that the regulatory requirements and the Department will place restrictions on the recoveries related to the 2000, 2001 and 2002 Med Supp Pool years and will require us to use the funds to ameliorate future Medicare Supplemental rate increases. Our belief is based upon historical actions taken by the Department. Accordingly, we have established a premium stabilization reserve which offset the income statement impact of the Med Supp Pool receivables established for years 2000 through 2002.

 

30


Table of Contents

IBM Agreement

 

In June 2002, we entered into a ten-year agreement with IBM to modernize our systems applications and operate our data center and technical help desk. Our payments to IBM for operating our data center and technical help desk will be based upon actual utilization of services billed at the rates established in the agreement. Under the terms of the contract, we are working jointly with IBM to modernize our systems applications, centered around a new claims payment system being developed by deNovis, Inc., a privately held startup company, in coordination with IBM and which will be licensed to us in perpetuity.

 

The agreement also provides for IBM to assist us in modernizing our other systems. In connection with these services, we have agreed to purchase up to $65.0 million in modernization services from IBM for a four year period beginning in 2002, with a target purchase rate of $7.3 million, $28.3 million, $19.0 million, $7.2 million and $3.2 million during 2002, 2003, 2004, 2005 and 2006, respectively. We may defer the purchase of services beyond the target date, provided that to the extent we delay purchases more than one year beyond the target year, we must pay a premium to IBM of 10% per annum of the target purchases more than one year beyond the target year less actual purchases. The amount that we will actually spend for these integration and modernization services could be less or greater than the annual target purchase rate, though over the term we anticipate that the amount we will actually spend for these services could be significantly greater than those contractual minimums. Actual expenses incurred related to these purchases were $4.2 million for the year ended December 31, 2002 and $3.1 million for the six months ended June 30, 2003. We expect to spend approximately $4.0 million on modernization initiatives during the balance of 2003. We expect that our spending on modernization will continue to be at levels consistent with our overall expectations of administrative expenses as a percentage of premiums earned and administrative service fees.

 

Investments

 

We classify all of our fixed maturity and marketable equity investments as either available for sale or trading and, accordingly, they are carried at fair value. The fair value of investments in fixed maturities and marketable equity securities are based on quoted market prices. Unrealized gains and losses on available for sale securities are reported as a separate component of other comprehensive income, net of deferred income taxes. The amortized cost of fixed maturities, including certain trust preferred securities, is adjusted for amortization of premiums and accretion of discounts to maturity, which is included in investment income. Amortization of premiums and discounts on collateralized mortgage obligations are adjusted for prepayment patterns using the retrospective method. Investment income is shown net of investment expenses. The cost of securities sold is based on the specific identification method. When the fair value of any investment is lower than its cost and such a decline is determined to be other than temporary, the cost of the investment is written down to fair value and the amount of the write down is charged to net income as a realized loss.

 

Short-term investments consist principally of U.S. treasury bills, commercial paper and money market investments. We consider securities with maturities greater than three months and less than one year at the date of purchase as short-term investments. The fair value of short-term investments is based on quoted market prices.

 

Other long-term equity investments, which include joint ventures, which are accounted for under the equity method, and derivative instruments, which are accounted for at fair value.

 

Our insurance company subsidiaries are subject to state laws and regulations that require diversification of their investment portfolios and limit the amount that may be invested in certain

 

31


Table of Contents

investment categories, such as below-investment-grade fixed income securities, mortgage loans, real estate and equity investments. Failure to comply with these laws and regulations might cause investments exceeding regulatory limitations to be treated as non-admitted assets for purposes of measuring statutory surplus and risk-based capital and, in some instances, require the sale of those investments.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Our fixed maturity and marketable equity securities are subject to the risk of potential losses from adverse market conditions. To manage the potential for economic losses, we regularly evaluate certain risks, as well as the appropriateness of the investments, to ensure the portfolio is managed within its risk guidelines. The result is a portfolio that is well diversified. Our primary risk exposures are changes in market interest rates, credit quality and changes in equity prices. The market value of our investments varies from time to time depending on economic and market conditions.

 

Interest Rate Risk

 

Interest rate risk is defined as the potential for economic losses on fixed-rate securities due to an adverse change in market interest rates. Our fixed maturity portfolio consists exclusively of U.S. dollar-denominated assets, invested primarily in U.S. government securities, corporate bonds, asset-backed bonds and mortgage-related securities, all of which represent an exposure to changes in the level of market interest rates. We manage interest rate risk by maintaining a duration commensurate with our insurance liabilities and policyholders’ surplus. Further, we do not engage in the use of derivatives to manage interest rate risk. A hypothetical increase in interest rates of 100 basis points would result in an estimated decrease in the fair value of the fixed income portfolio at June 30, 2003 of approximately $46.0 million.

 

Credit Quality Risk

 

Credit quality risk is defined as the risk of a credit downgrade to an individual fixed income security and the potential loss attributable to that downgrade. We manage this risk through our investment policy, which establishes credit quality limitations on the overall portfolio as well as dollar limits for individual issuers. The result is a well-diversified portfolio of fixed income securities, with an average credit rating of approximately “AA.”

 

Equity Price Risk

 

Equity price risk for stocks is defined as the potential for economic losses due to an adverse change in equity prices. Equity risk exposure is managed through our investment in an indexed mutual fund. Specifically, we are invested in ML S&P 500 Index LLC, which is an S&P 500 index mutual fund, resulting in a well-diversified and liquid portfolio that replicates the risk and performance of the broad U.S. stock market. We also hold a direct common stock investment in WebMD and investments in non-redeemable preferred stock of several companies. Our investment in non-redeemable preferred stock is managed in conjunction with our fixed maturity portfolio. In addition, our equity portfolio includes equity investments held in our nonqualified deferred compensation plans. We estimate our equity price risk from a hypothetical 10% decline in the S&P 500 and the relative effect of that decline in the value of our marketable equity portfolio at June 30, 2003 to be a decrease in fair value of $4.8 million.

 

32


Table of Contents

Fixed Income Securities

 

Our fixed income strategy is to construct and manage a high quality, diversified portfolio of securities. Additionally, our investment policy establishes minimum quality and diversification requirements resulting in an average credit rating of approximately “AA.” The average duration of our fixed income portfolio as of June 30, 2003 is 2.2 years.

 

Item 4. Controls and Procedures.

 

(a) We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to our management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our management, including the principal executive officer and the principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

(b) As of the end of the period covered by this quarterly report on Form 10-Q, we have carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective at the “reasonable assurance” level.

 

(c) There have been no significant changes in our internal controls or in other factors, which could significantly affect the internal controls subsequent to the date of their evaluation in connection with the preparation of this quarterly report on Form 10-Q.

 

33


Table of Contents

PART II

OTHER INFORMATION

 

Item 1.   Legal Proceedings.

 

Consumers Union of the U.S., Inc. et. al.    On August 21, 2002, Consumers Union of the U.S., Inc., the New York Statewide Senior Action Council and several other groups and individuals filed a lawsuit in New York Supreme Court against the State of New York, the New York State Superintendent of Insurance, or Superintendent, The New York Public Asset Fund, or the Fund, HealthChoice and its board of directors, among others, challenging the Conversion Legislation on several constitutional grounds, including that it impairs the plaintiffs’ contractual rights, it impairs the plaintiffs’ property rights without due process of law, and constitutes an unreasonable taking of property. In addition, the lawsuit alleges that HealthChoice has violated Section 510 of the New York Not-For-Profit Corporation Law and that the directors of HealthChoice breached their fiduciary duties, among other things, in approving the plan of conversion. The complaint seeks a permanent injunction against the conversion or portions thereof, including a redirection of the proceeds received from the sale of shares by our largest stockholder, the Fund, to uses that are charitable in nature.

 

By a motion dated September 20, 2002, we and the State defendants moved on several grounds to dismiss plaintiffs’ complaint in its entirety. In our motion, we argued first, that plaintiffs’ entire complaint should be dismissed because the issue of how best to use HealthChoice’s value to advance the public’s health and welfare raised by the complaint is a non-justiciable political question that is the sole province of the Legislature and beyond review by the courts. Second, we argued that plaintiffs’ constitutional claims based upon violations of the contracts, due process, and takings clauses should be dismissed because plaintiffs failed to allege a state action, a cognizable property or contractual right, or that the procedures pursuant to which any conversion would take place do not comport with due process safeguards. We argued further that plaintiffs’ state law claims should be dismissed because the Conversion Legislation supersedes any state provisions allegedly violated; plaintiffs failed to plead that our board of director’s decision to pursue the conversion constitutes a breach of fiduciary duty; plaintiffs did not plead all of the elements of constructive trust against any defendant; and plaintiffs’ allegation that the Conversion Legislation does not apply to HealthChoice is contradicted by the statute itself and by the decision of the Superintendent to approve the plan of conversion, which allegation plaintiffs seek to withdraw.

 

On November 6, 2002, pursuant to a motion filed by plaintiffs, the New York Supreme Court issued a temporary restraining order enjoining and restraining the transfer of the proceeds of the sale of common stock by the selling stockholders in our initial public offering to the Fund or The New York Charitable Asset Foundation or to the State or any of its agencies or instrumentalities. The court also ordered that such proceeds be deposited with the Comptroller of the State of New York pending the outcome of this action. The court did not enjoin WellChoice, HealthChoice or the other defendants from completing the conversion or the initial public offering or the receipt by WellChoice of the net proceeds from its issuance and sale of shares in the initial public offering. A court conference was held on November 26, 2002, at which time the motion to dismiss and the motion to convert the temporary restraining order into a preliminary injunction were deemed submitted. On March 6, 2003, the court delivered its decision dated February 28, 2003, in which it dismissed all of the plaintiffs’ claims in the complaint. The decision granted two of the plaintiffs, Consumers Union and one other group, leave to replead the complaint within 30 days of the decision to allege that the Conversion Legislation violates the State Constitution on the ground that it applies exclusively to HealthChoice. On April 1, 2003, the plaintiffs served an amended complaint, asserting the State constitutional claim as suggested in the court’s decision. The plaintiffs also appealed the court’s decision to dismiss but have not yet perfected their

 

34


Table of Contents

appeal. On May 28, 2003, the defendants’ motions to dismiss the amended complaint in its entirety, for failure to state a claim were fully submitted to the court. We are awaiting a decision. Pending a further order of the court, the temporary restraining order remains in effect and the plaintiffs’ motion for a preliminary injunction is deferred.

 

Thomas, et al. v. Empire, et al.    By a summons dated June 5, 2003 and a complaint dated May 22, 2003, and served upon Empire on June 10, 2003, this putative class action was commenced in the United States District Court for the Southern District of Florida, Miami Division. In addition to Empire, the other named defendants are the Blue Cross Blue Shield Association and substantially all of the other Blue plans in the country. The named plaintiffs, Drs. Thomas and Michael Kutell and the Connecticut State Medical Society, bring this case on their own behalf and also purport to bring it on behalf of similarly situated physicians and seek damages and injunctive relief to redress their claim of economic losses which they allege is the result of defendants, on their own and as part of a common scheme, systemically denying, delaying and diminishing claim payments. More specifically, plaintiffs allege that the defendants deny payment based upon cost or actuarial criteria rather than medical necessity or coverage, improperly downcode and bundle claims, refuse to recognize modifiers, intentional delay payment by pending otherwise payable claims and through calculated understaffing, use explanation of benefits, or EOBs, that fraudulently conceal the true nature of what was processed and paid and, finally, by use of capitation agreements which are structured to frustrate a provider’s ability to maximize reimbursement under the capitated agreement. The plaintiffs allege that the co-conspirators include not only the named defendants but also other insurance companies, trade associations and related entities such as Milliman and Robertson (actuarial firm), McKesson (claims processing software company), National Committee for Quality Assurance, Health Insurance Association of America, the American Association of Health Plans and the Coalition for Quality Healthcare. In additional to asserting a claim for declaratory and injunctive relief to prevent future damages, plaintiffs assert several causes of action based upon civil RICO and mail fraud. The time in which to appear and answer or to otherwise move to dismiss the complaint has been extended to August 11, 2003. We expect to move to dismiss the complaint on several grounds.

 

Item 4.   Submission of Matters to a Vote of Security Holders

 

(a) The Company held its annual meeting of stockholders on June 18, 2003 and solicited votes by proxy in connection with such meeting.

 

(b) The following matters were approved by the stockholders:

 

(i) The approval of management’s nominees as Class I Directors to the Board of Directors with the nominees receiving the following votes:

 

     FOR

   AGAINST

Michael A. Stocker, MD

   80,024,670    127,205

Robert R. McMillan

   79,776,570    375,305

John E. Zuccotti

   79,745,070    406,805

Peter Hutchings

   79,776,570    375,305

Susan L. Malley, Ph.D.

   80,084,670    67,205

 

35


Table of Contents

(ii) The stockholders approved the WellChoice, Inc. 2003 Omnibus Incentive Plan as follows: 63,435,301 votes in favor and 13,400,825 against. There were 1,370,712 abstentions and 1,945,037 broker non-votes.

 

(iii) The stockholders approved the WellChoice, Inc. 2003 Employee Stock Purchase Plan as follows: 73,159,480 in favor, and 3,677,121 against. There were 1,370,237 abstentions and 1,945,037 broker non-votes.

 

(iv) The ratification of the appointment of Ernst & Young LLP as our independent auditors for the year ending December 31, 2003. The proposal received 79,445,660 votes in favor and 687,490 against. There were also 18,725 abstentions.

 

Item 5.   Other Information.

 

On July 23, 2003, our Board of Directors amended the bylaws of WellChoice, Inc. to reduce the notice for special meetings of the Board of Directors from two days to one day and to make one word change in Section 3.04 thereof to clarify the intent of the provision. A copy of the Amended and Restated Bylaws, as so amended, is filed as Exhibit 3.2 to this report.

 

Item 6.   Exhibits and Reports on Form 8-K.

 

(a) Exhibits. The following exhibits to this report are being filed with this report (other than Exhibit 32.1 and 32.2 ,which are being furnished with this report):

 

Exhibit No.

  

Description


  3.2     

Amended and Restated Bylaws of WellChoice, as amended on July 23, 2003

10.24   

WellChoice, Inc. 2003 Omnibus Incentive Plan

10.25   

WellChoice, Inc. Employee Stock Purchase Plan

99.1     

Exhibit 31.1—Certification of CEO Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

99.2     

Exhibit 31.2—Certification of CFO Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

99.3     

Exhibit 32.1—Certification of CEO Pursuant to Section 906 of Sarbanes-Oxley Act of 2002

99.4     

Exhibit 32.2—Certification of CFO Pursuant to Section 906 of Sarbanes-Oxley Act of 2002

 

36


Table of Contents

(b) Current Reports on Form 8-K.

 

  (1)   On April 14, 2003, we filed with the Commission a Current Report on Form 8-K dated April 14, 2003, disclosing under Item 9 thereof the launch of the POS product for small group employers by our Empire Blue Cross Blue Shield subsidiaries.

 

  (2)   On April 24, 2003, we filed with the Commission a Current Report on Form 8-K dated April 12, 2003, disclosing under Item 9 and 12 our earnings for the three months ended March 31, 2003 and certain non-GAAP financial information and disclosing under Item 9 thereof the appointment of Gloria M. McCarthy as Executive Vice President and Chief Operating Officer and certain changes in our senior management.

 

  (3)   On May 12, 2003, we filed with the Commission a Current Report on Form 8-K dated May 12, 2003, disclosing under Item 9 thereof information relating to the potential impact to us of a budget bill passed by the New York State legislature.

 

  (4)   On May 12, 2003, we filed with the Commission a Current Report on Form 8-K dated May 12, 2003, reconfirming under Item 9 thereof our earnings guidance for the 2003 second quarter and for the 2003 year.

 

  (5)   On June 26, 2003, we filed with the Commission a Current Report on Form 8-K dated June 26, 2003, disclosing under Item 9 thereof the resignation of our Chief Sales Officer and disclosing that Jason Gorevic, our Senior Vice President and Chief Marketing Officer, would assume the additional responsibilities of Acting Head of Sales.

 

37


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: July 25, 2003

     

WELLCHOICE, INC.

(Registrant)

            By:  

/S/    JOHN W. REMSHARD


               

John W. Remshard

Senior Vice President and

Chief Financial Officer

 

38


Table of Contents

INDEX TO EXHIBITS

 

Number

  

Description


3.2     

Amended and Restated Bylaws of WellChoice, as amended on July 23, 2003

10.24   

WellChoice, Inc. 2003 Omnibus Incentive Plan

10.25   

WellChoice, Inc. Employee Stock Purchase Plan

99.1     

Exhibit 31.1—Certification of CEO Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

99.2     

Exhibit 31.2—Certification of CFO Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

99.3     

Exhibit 32.1—Certification of CEO Pursuant to Section 906 of Sarbanes-Oxley Act of 2002

99.4     

Exhibit 32.2—Certification of CFO Pursuant to Section 906 of Sarbanes-Oxley Act of 2002

 

39